NTN1 and neoplasm: These findings suggest that IGF2BP1 silencing inhibits the occurrence of tumor events through downregulating netrin-1 expression, indicating that the IGF2BP1/netrin-1 axis exerts an oncogenic role in high-glucose-treated NSCLC cells (33).